FDA describes 'objectionable conditions' at New York State Psychiatric Institute

Release Date:

The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.

FDA describes 'objectionable conditions' at New York State Psychiatric Institute

Title
'A catalyst for change': NIH makes first call for research supporting minimally verbal autistic people
Copyright
Release Date

flashback